IMS Health shares leap on private equity takeover talk

US— Shares in healthcare research giant IMS Health rose by 21% to $17.84 yesterday on the back of a report that the company is in talks with private equity firms over a possible sale.

The Wall Street Journal reported that the firm was in “advanced discussions” with potential suitors over a possible $3.5bn deal that could be finalised as early as next month.

Private equity houses being linked with the firm are TPG, Silver Lake and BC Partners, the report said, with the latter two forming a joint bid.

Neither IMS nor the private equity houses returned calls for comment today.

IMS Health came close to being bought by VNU (or what is now The Nielsen Company) in $7bn deal in 2005, but the deal began to fall apart when VNU shareholders blocked the move.

By the end of 2005, the deal had collapsed in the face of strong opposition from VNU shareholders and chairman and CEO Rob van den Bergh resigned from the company.

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

0 Comments

Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts